What You Should Know:
– Carta Healthcare®, which ignites healthcare improvement by unlocking the power of clinical data, expanded the strength and capabilities of its AI-powered platform with the acquisition of Realyze Intelligence.
– The Realyze Intelligence solution…
Continue Reading
What You Should Know:
– Certis Oncology Solutions, a translational science and emerging technology leader in preclinical oncology research, is pleased to announce the commercial launch of CertisOI Assistant™, an innovative chatbot tool designed to enhance…
Continue Reading
Editor’s Note: This is part two of our two-part interview with Dr. Karandeep Singh. To read part one, click here.Yesterday in our new series of articles, Chief AI Officers in Healthcare, we spoke with…
Continue Reading
Some big names in artificial intelligence have announced new healthcare partnerships, funding and implementations recently, across an array of clinical use cases. Here’s a sampling.
AI to improve cardiac MRIs
Amsterdam-based Royal Philips and Mayo Clinic…
For nearly 20 years, the worldwide healthcare safety organization ECRI has published its list of Top 10 Health Technology Hazards. This year’s edition is topped by a fast-changing technology with huge promise for healthcare,…
Continue Reading
The progress in artificial intelligence (AI) is reshaping patient care, across various dimensions, from facilitating faster discharge to curating treatment plans and suggesting lifestyle changes. However, one of the most notable benefits the medical…
Continue Reading
Pravin Tiwari, Executive Vice President and Business Unit Head, FPT Software
The promise of AI is greater efficiency in solving complex problems. But with that promise comes the responsibility of understanding and applying
governance, ethical, and…
Continue Reading
Editor’s Note: This is the second in our series, Chief AI Officers in Healthcare. To read the first, an interview with Dennis Chornenky at UC Davis Health, click here.Some health systems across the country…
Continue Reading
The Food and Drug Administration (FDA) has released guidance providing recommendations on what information should be included in a predetermined change control plan (PCCP) tailored to marketing AI-enabled medical devices.”This final guidance is part…
Continue Reading
The U.S. Food and Drug Administration has announced the availability of its final guidance on AI medical devices. The document – Marketing Submission Recommendations for a Predetermined Change Control Plan for Artificial Intelligence-Enabled Device Software…
Continue Reading
